Insilico Medicine founder and CEO Alex Zhavoronkov, Ph.D., presents on AI Drug Discovery for NIH National Institute on Drug Abuse
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven drug discovery company, will present ...